|
Market Closed -
Japan Exchange
10:30:00 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 6,822.00 JPY | +2.54% |
|
+0.40% | -17.24% |
Company Valuation: Chugai Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,141,311 | 5,540,406 | 8,789,053 | 11,516,953 | 13,565,544 | 11,224,255 | - | - |
| Change | - | -9.78% | 58.64% | 31.04% | 17.79% | -17.26% | - | - |
| Enterprise Value (EV) 1 | 5,669,311 | 5,051,408 | 8,050,071 | 10,520,608 | 13,138,942 | 10,199,308 | 10,059,514 | 9,778,935 |
| Change | - | -10.9% | 59.36% | 30.69% | 24.89% | -22.37% | -1.37% | -2.79% |
| P/E | 20.3x | 14.8x | 27x | 29.7x | 31.3x | 22x | 19.5x | 17.2x |
| PBR | 5.17x | 3.89x | 5.41x | 6.06x | 6.7x | 4.98x | 4.36x | 3.81x |
| PEG | - | 0.6x | -2.1x | 1.6x | 2.6x | 1.3x | 1.5x | 1.3x |
| Capitalization / Revenue | 6.14x | 4.4x | 7.91x | 9.84x | 10.8x | 8.06x | 7.37x | 6.76x |
| EV / Revenue | 5.67x | 4.01x | 7.24x | 8.99x | 10.4x | 7.32x | 6.61x | 5.89x |
| EV / EBITDA | 12.3x | 8.93x | 17.1x | 18.3x | 20.4x | 13.7x | 12.2x | 10.5x |
| EV / EBIT | 13.4x | 9.47x | 18.3x | 19.4x | 21.9x | 14.6x | 12.7x | 11x |
| EV / FCF | 35.3x | 27.7x | 21.6x | 47.8x | 71x | 23.1x | 19.7x | 16.5x |
| FCF Yield | 2.83% | 3.61% | 4.63% | 2.09% | 1.41% | 4.32% | 5.09% | 6.07% |
| Dividend per Share 2 | 76 | 78 | 80 | 98 | 272 | 134.9 | 152.5 | 171.6 |
| Rate of return | 2.03% | 2.32% | 1.5% | 1.4% | 3.3% | 1.98% | 2.24% | 2.52% |
| EPS 2 | 184.3 | 227.6 | 197.8 | 235.4 | 263.7 | 309.6 | 350.5 | 395.8 |
| Distribution rate | 41.2% | 34.3% | 40.4% | 41.6% | 103% | 43.6% | 43.5% | 43.4% |
| Net sales 1 | 999,800 | 1,259,946 | 1,111,367 | 1,170,611 | 1,257,900 | 1,392,745 | 1,521,950 | 1,659,754 |
| EBITDA 1 | 459,100 | 565,376 | 470,914 | 573,667 | 643,900 | 741,945 | 826,993 | 927,753 |
| EBIT 1 | 421,900 | 533,309 | 439,174 | 542,002 | 598,800 | 698,210 | 791,140 | 889,578 |
| Net income 1 | 303,000 | 374,429 | 325,472 | 387,317 | 434,000 | 509,575 | 576,828 | 651,341 |
| Net Debt 1 | -472,000 | -488,998 | -738,982 | -996,345 | -426,602 | -1,024,947 | -1,164,741 | -1,445,320 |
| Reference price 2 | 3,735.00 | 3,368.00 | 5,342.00 | 6,999.00 | 8,243.00 | 6,822.00 | 6,822.00 | 6,822.00 |
| Nbr of stocks (in thousands) | 1,644,260 | 1,645,014 | 1,645,274 | 1,645,514 | 1,645,705 | 1,645,303 | - | - |
| Announcement Date | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.03x | 7.32x | 13.75x | 1.98% | 71.26B | |
| 41.42x | 14.04x | 31.11x | 0.48% | 1,263B | |
| 39.99x | 6.71x | 18.89x | 1.95% | 658B | |
| 36.71x | 8.6x | 17.71x | 2.33% | 521B | |
| 21.74x | 5.27x | 13.12x | 2.48% | 391B | |
| 106.24x | 6.06x | 25.8x | 2.28% | 369B | |
| 23.19x | 5.95x | 14.36x | 2.69% | 307B | |
| 24.47x | 4.89x | 13.59x | 1.77% | 290B | |
| 29.55x | 7.53x | 13.48x | 2.16% | 252B | |
| -41.18x | 7.46x | 46.76x | 1.93% | 212B | |
| Average | 30.42x | 7.38x | 20.86x | 2.01% | 433.32B | |
| Weighted average by Cap. | 36.91x | 8.81x | 22.66x | 1.7% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4519 Stock
- Valuation Chugai Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
